• Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer 

      Ottestad, Anine Larsen; Hong, Yan Dai; Halvorsen, Tarje Onsøien; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning (Peer reviewed; Journal article, 2021)
      Introduction: Studies have indicated that detection of mutated KRAS or EGFR in circulating tumor DNA (ctDNA) from pre-treatment plasma samples is a negative prognostic factor for non-small cell lung cancer (NSCLC) pa-tients. ...
    • Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer 

      Falk, Philip; Severin, Mira; Berglund, Åke; Guren, Marianne; Hofsli, Eva; Österlund, Pia; Tandberg, Anne; Eberhard, Jakob; Sorbye, Halfdan (Peer reviewed; Journal article, 2022)
      Background The incidence of colorectal cancer (CRC) in individuals of fertile age is increasing. Oxaliplatin is a cornerstone treatment in the adjuvant setting for stage III and high-risk stage II CRC. Limited data exist ...